SCHEMBL7676393

SCHEMBL7676393

CC(C)Oc1cc2c(c(C(=O)Cl)c1)CCCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.41
▸ HPGD P15428 4/20 0.37
▸ TSHR P16473 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ NLRP3 Q96P20 1/20 0.36
▸ LMNA P02545 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KAT6A Q92794 1/20 0.34
▸ ACACB O00763 1/20 0.34
▸ ADCY8 P40145 1/20 0.33
▸ ADCY1 Q08828 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ KDM4C Q9H3R0 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7675116 0.87 ALDH1A1 (0.53) ALDH1A1HPGDTSHRKDM4EHSD17B10
SCHEMBL7677714 0.83 CXCR5 (0.42) ALDH1A1TSHRKDM4EHSD17B10NLRP3
SCHEMBL15661298 0.73 ALDH1A1 (0.40) ALDH1A1HPGDTSHRKDM4EHSD17B10
SCHEMBL7681591 0.69 CXCR5 (0.48) ALDH1A1HPGDTSHRKDM4EHSD17B10
SCHEMBL16473527 0.69 TSHR (0.50) ALDH1A1HPGDTSHRKDM4EHSD17B10
SCHEMBL7678090 0.68 CXCR5 (0.44) ALDH1A1HPGDTSHRKDM4EHSD17B10
SCHEMBL4266407 0.68 XDH (0.47) ALDH1A1HPGDKDM4ENLRP3NPC1
SCHEMBL7677787 0.67 SMN1; SMN2 (0.45) ALDH1A1TSHRNLRP3LMNAKMT2A
SCHEMBL1814578 0.67 KMT2A (0.47) ALDH1A1KMT2AMEN1GAAHTT
SCHEMBL19579749 0.66 RXRA (0.40) ALDH1A1HPGDTSHRKDM4ENLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403601-B1 TREATMENT OF ASTHMA, ANXIETY, DEPRESSION, EMESIS, URINARY INCONTINENCE AND RELATED CONDITIONS. ASTRAZENECA AB (SE) 2002-06-11 — — US disclosed
EP-1137637-A1 N-(2-PHENYL-4-PIPERIDINYLBUTYL)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENECARBOXAMIDES AND THEIR USE AS NEUROKININ 1 (NK1) AND/OR NEUROKININ 2 (NK2) RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-10-04 — — EP disclosed
WO-2000034243-A1 N-(2-PHENYL-4-PIPERIDINYBUTYL)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENECARBOXAMIDES AND THEIR USE AS NEUROKININ 1 (NK1) AND/OR NEUROKININ 2 (NK2) RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-06-15 — — WO disclosed
Send feedback